Disruptive Pharma AB
Disruptive Pharma develops novel drug products using its proprietary Pharma-MMC platform, which utilizes mesoporous magnesium carbonate to create amorphous solid dispersions that enhance drug dissolution and absorption. This technology addresses the challenge of formulating difficult-to-deliver drugs, enabling the development of therapeutically equivalent or improved formulations from approved active pharmaceutical ingredients.
- Biotechnology
Updated 15 days ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- Disruptive Pharma develops novel drug products using its proprietary Pharma-MMC platform, which utilizes mesoporous magnesium carbonate to create amorphous solid dispersions that enhance drug dissolution and absorption. This technology addresses the challenge of formulating difficult-to-deliver drugs, enabling the development of therapeutically equivalent or improved formulations from approved active pharmaceutical ingredients.